Table 1.
IMN in pediatric patients: clinical and laboratory data (N = 13)
| Initial Visit N (%) | Final Visit n (%) | |
| Mean Age | 9.6 ± 4.6 | -- |
| Gender | 6 M:7 F | -- |
| Ethnicity | 8 W:2 B:3 H | -- |
| Hematuria | 9 (69%) | 6 (46%) |
| Peripheral Edema | 5 (38%) | 0 |
| Proteinuria (protein:creatinine ratio) | 3.3 ± 2.5 | 2.3 ± 3.1 |
| Nephrotic-range Proteinuria | 5 (38%) | 3 (23%) |
| Hypoalbuminemia | 6 (46%) | 5 (38%) |
| Hypertension | 3 (23%) | 7 (54%) |
| Hypercholesterolemia | 10 (77%) | 5 (38%) |
| GFRemL/min/m2 | 155 ± 34 | 127 ± 57 |
| CKD Stage 3–5 | 0 | 3 (23%) |
Abbreviations: CKD, Chronic kidney disease; GFRe, Estimated glomerular filtration rate